Chinese breast cancer experts will speak during a Tuesday morning session before the official start of the 2025 San Antonio Breast Cancer Symposium. The session will highlight advances in breast cancer care in China. An international panel discussion will also take place.
Several novel agents, including novel ADCs, are being developed in China that will find their way into clinics, said Dr. Virginia Kaklamani, co-chair of SABCS.
“This is the best opportunity to familiarize yourselves with these agents,” she said.
The session is one of several Ancillary Educational Events held in conjunction with SABCS but not part of the symposium. It offers a unique opportunity to hear what is happening in breast cancer research in China from the Chinese Breast Cancer Society. The session is scheduled for 7:45 – 9:15 AM Tuesday, December 9, in Room 301 ABC in the Henry B. Gonzalez Convention Center.